Evidence map›Paper›PMID 40642981›Full record

ArticleMicrobiology spectrum2025

Dysbiosis-associated gut bacterium

Olga M Sokolovskaya, Jasmina Uzunovic, Yutian Peng, Mikiko Okumura, Lingjue Mike Wang, Yuhui Zhou, Zijuan Lai, Elizabeth Skippington, Man-Wah Tan

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Observational
  3. Supplementation withThe veterinary quarterly · 2026
    Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Olga M SokolovskayaDepartment of Infectious Diseases & Host-Microbe Interactions, Genentech, Inc., South San Francisco, California, USA.ORCID 0000-0003-1202-4248
Jasmina UzunovicDepartment of OMNI Bioinformatics, Genentech Inc., South San Francisco, California, USA.
Yutian PengDepartment of Infectious Diseases & Host-Microbe Interactions, Genentech, Inc., South San Francisco, California, USA.ORCID 0000-0002-8663-7330
Mikiko OkumuraDepartment of Discovery Chemistry, Genentech, Inc., South San Francisco, California, USA.
Lingjue Mike WangDepartment of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, California, USA.
Yuhui ZhouDepartment of Discovery Chemistry, Genentech, Inc., South San Francisco, California, USA.
Zijuan LaiDepartment of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, California, USA.
Elizabeth SkippingtonDepartment of OMNI Bioinformatics, Genentech Inc., South San Francisco, California, USA.
Man-Wah TanDepartment of Infectious Diseases & Host-Microbe Interactions, Genentech, Inc., South San Francisco, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IMPORTANCE:

Indexed as

DysbiosisEubacterialesGastrointestinal MicrobiomeMucinsN-Acetylneuraminic AcidRuminococcusGenome, BacterialHumansInflammatory Bowel DiseasesPhylogenyMucinsN-Acetylneuraminic Acid2,7-anhydro-Neu5Acmucin glycansRuminococcus gnavussialic acidstrain-level diversity

Identifiers

PMID40642981
PMCPMC12323340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.